136 related articles for article (PubMed ID: 10568485)
1. Immunomodulators in the treatment of cutaneous lymphoma.
Rogalski C; Dummer R; Burg G
J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):83-90. PubMed ID: 10568485
[TBL] [Abstract][Full Text] [Related]
2. Experimental therapies in the treatment of cutaneous T-cell lymphoma.
Foss FM; Kuzel TM
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1127-37. PubMed ID: 8522489
[TBL] [Abstract][Full Text] [Related]
3. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL).
Dummer R
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
5. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with autologous bone-marrow transplantation: rationale and results.
Bilgrami S; Silva M; Cardoso A; Miller KB; Ascensao JL
Exp Hematol; 1994 Oct; 22(11):1039-50. PubMed ID: 7523161
[No Abstract] [Full Text] [Related]
7. [Immuno-intervention in cutaneous lymphomas].
Dummer R; Heinzerling L; Schmid MH; Burg G
Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
[TBL] [Abstract][Full Text] [Related]
8. Biologic agents and approaches in the management of patients with lymphoma. A critical appraisal.
Longo DL
Hematol Oncol Clin North Am; 1991 Oct; 5(5):1067-87. PubMed ID: 1718939
[TBL] [Abstract][Full Text] [Related]
9. New therapies for cutaneous T-cell lymphoma.
Heald PW; Edelson RL
Arch Dermatol; 1987 Feb; 123(2):189-91. PubMed ID: 2949704
[No Abstract] [Full Text] [Related]
10. Monoclonal antibodies and autologous stem cell transplantation for lymphoma.
Flinn IW; Lazarus HM
Bone Marrow Transplant; 2001 Mar; 27(6):565-9. PubMed ID: 11319583
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulators in the treatment of cutaneous lymphomas.
Dummer R
Expert Opin Biol Ther; 2002 Mar; 2(3):279-86. PubMed ID: 11890867
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cutaneous T-cell lymphoma.
Vonderheid EC; Micaily B
Dermatol Clin; 1985 Oct; 3(4):673-87. PubMed ID: 3916174
[TBL] [Abstract][Full Text] [Related]
13. [The role of interleukin-2--based immunotherapy in hematological malignancies].
Ackerstein A; Toren A; Slavin S; Nagler A
Harefuah; 1996 May; 130(9):613-7. PubMed ID: 8794642
[No Abstract] [Full Text] [Related]
14. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
16. Standard and experimental therapy in cutaneous T-cell lymphomas.
Dummer R; Cozzio A; Meier S; Beyeler M; Laetsch B; Doebbeling U; Urosevic M
J Cutan Pathol; 2006 Feb; 33 Suppl 1():52-7. PubMed ID: 16412213
[TBL] [Abstract][Full Text] [Related]
17. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
Burns LJ; Weisdorf DJ; DeFor TE; Vesole DH; Repka TL; Blazar BR; Burger SR; Panoskaltsis-Mortari A; Keever-Taylor CA; Zhang MJ; Miller JS
Bone Marrow Transplant; 2003 Jul; 32(2):177-86. PubMed ID: 12838283
[TBL] [Abstract][Full Text] [Related]
18. [Cancer therapy with monoclonal antibody].
Irie RF; Hachida M
Tanpakushitsu Kakusan Koso; 1986 Nov; 31(14):1501-10. PubMed ID: 3544072
[No Abstract] [Full Text] [Related]
19. Current management strategies for cutaneous T-cell lymphoma.
Knobler E
Clin Dermatol; 2004; 22(3):197-208. PubMed ID: 15262305
[TBL] [Abstract][Full Text] [Related]
20. [New aspects of immunotherapy of malignant melanoma].
Enk A
Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
